StockWatch
·
Misc Health and Biotechnology Services
Quarterly ResultAug 5, 2026, 04:21 PM

agilon health Swings to Q2 Profit of $18.0M; EPS $1.04

AI Summary

agilon health, inc. reported a significant turnaround, achieving a net income of $18.0 million for the second quarter of 2026, compared to a net loss of $104.4 million in the prior year. Diluted earnings per share for the quarter were $1.04, a substantial improvement from a loss of $6.31 per share. For the six months ended June 30, 2026, the company posted a net income of $66.9 million and diluted EPS of $3.96, reversing a net loss of $92.3 million and EPS of $(5.58) in the same period last year. The company also completed a 1-for-25 reverse stock split on March 30, 2026.

Key Highlights

  • Q2 2026 net income was $18.0 million, up from a $104.4 million net loss in Q2 2025.
  • Q2 2026 diluted EPS was $1.04, compared to $(6.31) in Q2 2025.
  • Six-month 2026 net income was $66.9 million, reversing a $92.3 million loss in 2025.
  • Six-month 2026 diluted EPS was $3.96, compared to $(5.58) in 2025.
  • Medical services revenue for Q2 2026 increased to $1.49 billion from $1.39 billion.
  • Total assets increased to $1.59 billion as of June 30, 2026, from $1.27 billion.
  • Net cash used in operating activities improved to $(33.6) million for six months.
  • A 1-for-25 reverse stock split was effected on March 30, 2026.